AAHIVM event: Pain Management for HIV Patients

The novel drug combines a fourth-generation cephalosporin with a novel extended-spectrum β-lactamase inhibitor.

Drug resistance has physicians racing to find alternative therapies for many infections. In a new non-inferiority study, fosfomycin was inferior to more common therapies.

Gram-negative bacteria can cause infections, are resistant to multiple drugs, and are increasingly resistant to most available antibiotics, the CDC says.